Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 321-340
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Jonathan Blankfein Investor at Catalio Capital Management | New York, United States | Venture capitalVenture debt | AIHealthcare | ||
 Jareth van der Putten Investor at Innovationquarter | Netherlands | Government-backed | AIClimate | ||
 Anthony Jean Gilles NIH STTR BIOTECH venture/angel investor at The National Institutes of Health | United States | Government-backed | Healthcare | ||
 David Parker General Partner at Ampersand Capital Partners | Boston, United States | Private equity | CommerceHardware | ||
 Ashri Jaiswal Angel Investor at LVX | Bengaluru, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | ||
 Janice Y. Lederman Former Director at Genome Canada | Winnipeg, Canada | Government-backedVenture debt | FinTechHealthcare | ||
 Adrià Roca Valls Investment Director in Venture Capital at Inveready | Spain | Private equityVenture capital | AICommerce | ||
 Sandy Beatty Hedge Fund Investment Analyst at Marshall Wace | New York, United States | Private equityVenture debt | FinTechHealthcare | ||
 Michael Schklowski Venture Founder FarmRise One - Digital Farming at Bayer | Mumbai, India | Corporate VC | ClimateFood | ||
 Anne Portwich Partner at Eqt Life Sciences | Amsterdam, Netherlands | Private equityVenture capital | ClimateHardware | ||
 Tiffany Le Principal at New Enterprise Associates (NEA) | San Francisco, United States | Venture capital | AICommerce | ||
 Daniela Begolo Managing Director at Eqt Life Sciences | Amsterdam, Netherlands | Private equityVenture capital | Healthcare | ||
 John T. Dimos Member, National Programming Board at Startout | San Francisco, United States | AcceleratorCorporate VC | CommerceHealthcare | ||
 Kasia Konopacki Investor at Marshall Wace | Boston, United States | Private equityVenture debt | FinTechHealthcare | ||
 Christian Haigh CEO at Compound | San Francisco, United States | Venture capital | AIFinTech | ||
 Paul Sunzenauer Investor at Occident | Munich, Germany | Venture capital | HardwareHealthcare | ||
| San Francisco, United States | Private equityVenture capital | AIConsumer | |||
 Tom Melzer Investor at RiverVest Venture Partners | United States | Venture capital | HardwareHealthcare | ||
 Meghan Davis Senior Program Associate at Massachusetts Life Sciences Center | Somerville, United States | Government-backed | EducationHealthcare | ||
 John Josey Partner at The Column Group | Dallas, United States | Venture capital | Healthcare |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal